Worsening anxiety and depression after initiation of lumacaftor/ivacaftor combination therapy in adolescent females with cystic fibrosis.

Autor: McKinzie CJ; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, United States. Electronic address: cameron.mckinzie@unchealth.unc.edu., Goralski JL; Division of Pediatric Pulmonology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, United States; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, United States., Noah TL; Division of Pediatric Pulmonology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, United States., Retsch-Bogart GZ; Division of Pediatric Pulmonology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, United States., Prieur MB; Department of Psychiatry and Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, United States.

Publikováno v: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2017 Jul; Vol. 16 (4), pp. 525-527. Date of Electronic Publication: 2017 Jun 08.